Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-12-16
1999-01-12
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 6, 514 11, 514 12, 514192, 514200, A61K 3800, A61K 3816, A61K 3143, A61K 31545
Patent
active
058589627
ABSTRACT:
Lysostaphin is used to eliminate and cure staphylococcal infections including the cure of mastitis by intramammary infusion. Administration of from 2 mg to 400 mg of lysostaphin to an infected bovine mammary gland eliminates staphylococci, and the reoccurrence common with antibiotic therapy is not observed. Teat-dips containing lysostaphin, mutanolysin and lysozyme can be used as a prophylactic. Synergistic enhancement of the killing effect of lysostaphin is observed when a mild surfactant or penicillin or both is included in the formulation.
REFERENCES:
patent: 4980163 (1990-12-01), Blackburn et al.
Craven et al- Am J. Res. vol. 44, No. 4 709-712, Apr. 1983.
The Merck Veterinary Manual, Fifth ED., Merck & Co (1979) pp. 840-849.
Dixon et al - Yale Journal of Biology and Medicine vol. 41, Aug., 1968, pp. 62-68.
Jarrett-The Veterinary Clinics of North America 338-343.
The Merck Index, Merck & Co., Inc, 1983 p. 807.
Khan et al-J. Dairy Science vol. 52 No. 6, M79.
Blackburn Peter
Polak June
Ambi Inc.
Weddington Kevin E.
LandOfFree
Composition for treating mastitis and other staphylococcal infec does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition for treating mastitis and other staphylococcal infec, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for treating mastitis and other staphylococcal infec will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1515850